176 related articles for article (PubMed ID: 34262084)
21. Sphingolipid profile in the CNS of the twitcher (globoid cell leukodystrophy) mouse: a lipidomics approach.
Esch SW; Williams TD; Biswas S; Chakrabarty A; LeVine SM
Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):779-87. PubMed ID: 14528915
[TBL] [Abstract][Full Text] [Related]
22. Recent developments in the biochemistry of globoid and metachromatic leucodystrophies.
Farooqui AA; Mandel P
Biomedicine; 1977 Jul; 26(4):232-6. PubMed ID: 21709
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy.
Belleri M; Ronca R; Coltrini D; Nico B; Ribatti D; Poliani PL; Giacomini A; Alessi P; Marchesini S; Santos MB; Bongarzone ER; Presta M
Brain; 2013 Sep; 136(Pt 9):2859-75. PubMed ID: 23983033
[TBL] [Abstract][Full Text] [Related]
24. Krabbe disease: psychosine-mediated activation of phospholipase A2 in oligodendrocyte cell death.
Giri S; Khan M; Rattan R; Singh I; Singh AK
J Lipid Res; 2006 Jul; 47(7):1478-92. PubMed ID: 16645197
[TBL] [Abstract][Full Text] [Related]
25. Ceramide galactosyltransferase expression is regulated positively by Nkx2.2 and negatively by OLIG2.
Okahara K; Kizuka Y; Kitazume S; Ota F; Nakajima K; Hirabayashi Y; Maekawa M; Yoshikawa T; Taniguchi N
Glycobiology; 2014 Oct; 24(10):926-34. PubMed ID: 24821492
[TBL] [Abstract][Full Text] [Related]
26. Kidney lipids in galactosylceramide synthase-deficient mice. Absence of galactosylsulfatide and compensatory increase in more polar sulfoglycolipids.
Tadano-Aritomi K; Hikita T; Fujimoto H; Suzuki K; Motegi K; Ishizuka I
J Lipid Res; 2000 Aug; 41(8):1237-43. PubMed ID: 10946011
[TBL] [Abstract][Full Text] [Related]
27. Hematopoietic cell transplantation in murine globoid cell leukodystrophy (the twitcher mouse): effects on levels of galactosylceramidase, psychosine, and galactocerebrosides.
Ichioka T; Kishimoto Y; Brennan S; Santos GW; Yeager AM
Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4259-63. PubMed ID: 2884662
[TBL] [Abstract][Full Text] [Related]
28. Oligodendrocyte-specific ceramide galactosyltransferase (CGT) expression phenotypically rescues CGT-deficient mice and demonstrates that CGT activity does not limit brain galactosylceramide level.
Zöller I; Büssow H; Gieselmann V; Eckhardt M
Glia; 2005 Nov; 52(3):190-8. PubMed ID: 15968630
[TBL] [Abstract][Full Text] [Related]
29. [Pathophysiology of sulfatide metabolism in metachromatic leukodystrophy].
Wiesmann UN
Bull Schweiz Akad Med Wiss; 1978 Mar; 34(1-3):33-47. PubMed ID: 27269
[TBL] [Abstract][Full Text] [Related]
30. Biochemical aspects of globoid and metachromatic leukodystrophies.
Farooqui AA; Horrocks LA
Neurochem Pathol; 1984; 2(3):189-218. PubMed ID: 6152665
[TBL] [Abstract][Full Text] [Related]
31. Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy.
Hawkins-Salsbury JA; Shea L; Jiang X; Hunter DA; Guzman AM; Reddy AS; Qin EY; Li Y; Gray SJ; Ory DS; Sands MS
J Neurosci; 2015 Apr; 35(16):6495-505. PubMed ID: 25904800
[TBL] [Abstract][Full Text] [Related]
32. Glycosylceramide synthesis in the developing spinal cord and kidney of the twitcher mouse, an enzymatically authentic model of human Krabbe disease.
Kodama S; Igisu H; Siegel DA; Suzuki K
J Neurochem; 1982 Nov; 39(5):1314-8. PubMed ID: 6811701
[TBL] [Abstract][Full Text] [Related]
33. Biochemical pathogenesis of demyelination in globoid cell leukodystrophy (Krabbe's disease): the effects of psychosine upon oligodendroglial cell culture.
Ida H; Eto Y; Maekawa K
Acta Paediatr Jpn; 1990 Feb; 32(1):20-6. PubMed ID: 2109485
[TBL] [Abstract][Full Text] [Related]
34. Zoledronate derivatives as potential inhibitors of uridine diphosphate-galactose ceramide galactosyltransferase 8: A combined molecular docking and dynamic study.
Pannuzzo G; Graziano AC; Pannuzzo M; Masman MF; Avola R; Cardile V
J Neurosci Res; 2016 Nov; 94(11):1318-26. PubMed ID: 27638613
[TBL] [Abstract][Full Text] [Related]
35. Bone marrow transplantation increases efficacy of central nervous system-directed enzyme replacement therapy in the murine model of globoid cell leukodystrophy.
Qin EY; Hawkins-Salsbury JA; Jiang X; Reddy AS; Farber NB; Ory DS; Sands MS
Mol Genet Metab; 2012 Sep; 107(1-2):186-96. PubMed ID: 22704480
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis of metachromatic leukodystrophy, Krabbe disease, and Farber disease after uptake of fatty acid-labeled cerebroside sulfate into cultured skin fibroblasts.
Kudoh T; Wenger DA
J Clin Invest; 1982 Jul; 70(1):89-97. PubMed ID: 6806321
[TBL] [Abstract][Full Text] [Related]
37. Substrate reduction intervention by L-cycloserine in twitcher mice (globoid cell leukodystrophy) on a B6;CAST/Ei background.
Biswas S; Biesiada H; Williams TD; LeVine SM
Neurosci Lett; 2003 Aug; 347(1):33-6. PubMed ID: 12865135
[TBL] [Abstract][Full Text] [Related]
38. Metabolism of cerebroside sulfate and subcellular distribution of its metabolites in cultured skin fibroblasts from controls, metachromatic leukodystrophy, and globoid cell leukodystrophy.
Inui K; Furukawa M; Okada S; Yabuuchi H
J Clin Invest; 1988 Feb; 81(2):310-7. PubMed ID: 3339122
[TBL] [Abstract][Full Text] [Related]
39. Quantification of sulfatides and lysosulfatides in tissues and body fluids by liquid chromatography-tandem mass spectrometry.
Mirzaian M; Kramer G; Poorthuis BJ
J Lipid Res; 2015 Apr; 56(4):936-43. PubMed ID: 25632048
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and structure-activity relationships of cerebroside analogues as substrates of cerebroside sulphotransferase and discovery of a competitive inhibitor.
Li W; Guillaume J; Baqi Y; Wachsmann I; Gieselmann V; Van Calenbergh S; Müller CE
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1503-1512. PubMed ID: 32657203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
